A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, Application In Synthesis of (1R,2R)-Cyclohexane-1,2-diamine, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 20439-47-8, Name is (1R,2R)-Cyclohexane-1,2-diamine, molecular formula is C6H14N2. In a Article, authors is Cermak, Diana M.，once mentioned of 20439-47-8
Several strategies for synthesis of nonracemic dimethyl alpha- (hydroxyfarnesyl)phosphonate and the parent phosphonic acid have been explored. Separation of diastereomeric derivatives prepared by esterification of racemic alpha-hydroxy phosphonate with (S)-(+)-O-methylmandelic acid was possible, and these diastereomers could be assigned absolute stereochemistry on the basis of literature precedent. However, hydrolysis to the alpha-hydroxy phosphonic acid was accompanied by extensive isomerization. Addition of a nonracemic phosphonamidite to farnesal also gave nonracemic material, but again hydrolysis was problematic. Oxidation of dimethyl farnesylphosphonate anion with nonracemic (camphorsulfonyl)oxaziridines was shown to be regio- and stereoselective for formation of the alpha-hydroxy phosphonate. Enantiomeric excess of ~70% ee was established by conversion of the oxidation products to their (S)-(+)-O-methylmandelate derivatives. Although hydrolysis of these methyl esters was accompanied by extensive racemization, both enantiomers of alpha-(hydroxyfarnesyl)phosphonic acid were obtained in low ee by this strategy.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 20439-47-8, help many people in the next few years.Application In Synthesis of (1R,2R)-Cyclohexane-1,2-diamine
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI